Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The overall objective of this study is to evaluate the clinical efficacy of oral famotidine
in symptomatic non-hospitalized patients with confirmed COVID-19. This study is expected to
enroll up to 84 patients with mild to moderate symptoms divided into each of the two study
arms. Clinical outcomes of the two treatment arms will be compared. This study will be
conducted virtually/remotely.